Scarica l'app Stockscreener
0.3103
6.90%
0.0203
Precedente Chiudi:
$0.29
Aprire:
$0.2865
Volume 24 ore:
3.05M
Relative Volume:
0.88
Capitalizzazione di mercato:
$14.59M
Reddito:
-
Utile/perdita netta:
$-16.26M
Rapporto P/E:
-0.2627
EPS:
-1.1814
Flusso di cassa netto:
$-13.50M
1 W Prestazione:
+23.02%
1M Prestazione:
-7.46%
6M Prestazione:
-85.31%
1 anno Prestazione:
-92.77%
Intervallo 1D:
$0.2809
$0.315
Intervallo di 1 settimana:
$0.2534
$0.32
Portata 52W:
$0.1853
$4.40
Intensity Therapeutics Inc Stock (INTS) Company Profile
Nome
Intensity Therapeutics Inc
Settore
Industria
Telefono
203-221-7381
Indirizzo
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Confronta INTS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.31 | 13.83M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.61 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.60 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.24 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
649.05 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.55 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
Detecting support and resistance levels for Intensity Therapeutics Inc.2025 Macro Impact & AI Forecasted Stock Moves - Newser
Can a trend reversal in Intensity Therapeutics Inc. lead to recoveryJuly 2025 Sector Moves & Growth Focused Stock Reports - Newser
Analyzing recovery setups for Intensity Therapeutics Inc. investors2025 Risk Factors & Daily Chart Pattern Signals - Newser
Intensity Therapeutics Reports Reduced Losses and Clinical Progress - TipRanks
Using data filters to optimize entry into Intensity Therapeutics Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
Intensity Therapeutics Inc (INTS) Stock: Navigating a Year of Volatility - investchronicle.com
Shelton-based biotech regains Nasdaq compliance - Hartford Business Journal
Is now a turning point for Intensity Therapeutics Inc.July 2025 Action & Free Growth Oriented Trading Recommendations - Newser
Intensity (INTS) Q2 Net Loss Drops 50% - AOL.com
Intensity Therapeutics Amends Bylaws for Quorum Change - MSN
Sentiment analysis tools applied to Intensity Therapeutics Inc.Free Triple Digit Return Stock Predictions - Newser
Can momentum traders help lift Intensity Therapeutics Inc.New Guidance & Real-Time Market Trend Scan - Newser
How to recover losses in Intensity Therapeutics Inc. stock [2025 Pullback Review]Free Community Trade Idea Sharing Platform - Newser
Brookline Capital upgrades Intensity Therapeutics stock rating to Buy By Investing.com - Investing.com Australia
Intensity Therapeutics regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria
Intensity Therapeutics regains compliance with Nasdaq listing requirements - Investing.com
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - WV News
Intensity Therapeutics shares fall 2.96% premarket as health care sector sees mixed performance. - AInvest
How Intensity Therapeutics Inc. stock performs during market volatilityFree Stock Market Watch With Alerts - Newser
Using Python tools to backtest Intensity Therapeutics Inc. strategiesSwing Trade Entry and Exit Point Analysis - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionBuy and Hold Position Summary Review - Newser
Multi factor analysis applied to Intensity Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser
Is Intensity Therapeutics Inc. still worth holding after the dipStock Portfolio Risk and Return Analysis - Newser
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Morningstar
Is Intensity Therapeutics Inc. meeting your algorithmic filter criteriaTechnical Insight Guide for Safer Trades - Newser
Shelton biotech raises millions for novel cancer treatment - Hartford Business Journal
How to recover losses in Intensity Therapeutics Inc. stockLow Risk Strategy with Smart Entry Zones - Newser
why intensity therapeutics inc. stock attracts strong analyst attentionAI-Based Reversal Point Prediction Signal - Newser
Intensity Therapeutics Raises $6.6 Million in July Offering - TipRanks
Intensity Therapeutics Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Intensity Therapeutics raises $6.6M from ATM stock sales in July - TipRanks
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025 - Citizen Tribune
Biotech Intensity Therapeutics Secures $6.6M Funding at Premium Price, Extends Operations Through 2026 - Stock Titan
Is Intensity Therapeutics Inc. stock overvalued or undervaluedBuild wealth faster with consistent investment plans - Jammu Links News
What analysts say about Intensity Therapeutics Inc. stockUnlock superior stock analysis tools - Jammu Links News
What are analysts’ price targets for Intensity Therapeutics Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News
Is Intensity Therapeutics Inc. a good long term investmentFree Stock Selection - Jammu Links News
How does Intensity Therapeutics Inc. generate profit in a changing economyMaximize your returns with expert insights - Jammu Links News
Is it the right time to buy Intensity Therapeutics Inc. stockTremendous growth opportunities - Jammu Links News
How strong is Intensity Therapeutics Inc. company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News
Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):